Guarana: a natural energy boost for cancer fatigue?

NCT ID NCT07151391

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This phase 2 trial tests whether guarana, a natural supplement from the Amazon, can reduce fatigue in 86 people with neuroendocrine tumors or gynecologic cancers. Participants take either guarana or a placebo daily for up to 42 days, and researchers measure changes in fatigue using standard questionnaires. The goal is to see if guarana offers a safe, simple way to improve energy and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
guarana (Paullinia cupana) taken as a 500 mg oral capsule daily
What this could lead to
If it works, this could offer a natural, low-cost option to reduce fatigue in people with these cancers, improving daily life.
What could go wrong
This is a small, early-phase trial (86 people) testing a supplement, not a proven drug. Fatigue is subjective, and results may not be strong or lasting. Side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huntsman Cancer Institute at University of Utah

    RECRUITING

    Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.